Concepedia

Rabindranath Tripathy

RT

Statistics

Publications

16

Citations

718

H-Index

15

Active since

1988

Affiliations

Avalon Pharma (United States)(Current)

Brandywine Photonics (United States)

Rabindranath Tripathy is an author at Avalon Pharma (United States) specializing in pharmacology, drug discovery, and medicine.

Top concepts

PharmacologyMedicineDrug DiscoveryMedicinal ChemistryBiochemistryNatural SciencesChemistryEngineeringPharmacotherapyOrganic Chemistry

Publications per year

1988–2011

16

Publications

16

Structure-guided identification of novel VEGFR-2 kinase inhibitors via solution phase parallel synthesis

Rabindranath Tripathy, Alyssa Reiboldt, Patricia A. Messina et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 104 citations · Full text

Medicinal Chemistry, Drug Target, Medicine +9

Diels-Alder reaction of dienes having stereogenic allylic substituents: control of diastereoface selectivity by the dienophile

Rabindranath Tripathy, R. W. FRANCK, Kay D. Onan · Journal of the American Chemical Society · 1988 · 98 citations

Stereogenic Allylic Substituents, Engineering, Altmetric Attention Score +20

1,2,3-Thiadiazole substituted pyrazolones as potent KDR/VEGFR-2 kinase inhibitors

Rabindranath Tripathy, Arup K. Ghose, J. B. Singh et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 89 citations · Full text

Medicinal Chemistry, Medicine, Rational Drug Design +5

Effect of allylic substituents on the face selectivity of Diels-Alder reactions of semicyclic dienes

S. C. Datta, R. W. FRANCK, Rabindranath Tripathy et al. · Journal of the American Chemical Society · 1990 · 50 citations

Engineering, Chemical Analysis, Altmetric Attention Score +16

Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity

Gregory R. Ott, Rabindranath Tripathy, Mangeng Cheng et al. · ACS Medicinal Chemistry Letters · 2010 · 49 citations · Full text

Potent Inhibitor, Kinase Inhibitors, Anaplastic Lymphoma Kinase +18

1–5 of 16